Epidemiologic Changes Caused by the Preventive Measures for the Coronavirus Disease 2019 Pandemic: An Additional Challenge for Pediatricians
Epidemiologic Changes Caused by the Preventive Measures for the Coronavirus Disease 2019 Pandemic: An Additional Challenge for Pediatricians
- Discussion
63
- 10.1016/j.jpeds.2020.06.057
- Jun 22, 2020
- The Journal of Pediatrics
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features
- Research Article
17
- 10.1016/j.ejim.2021.10.006
- Oct 14, 2021
- European Journal of Internal Medicine
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations
- Research Article
5
- 10.1016/j.ajodo.2020.08.010
- Sep 21, 2020
- American Journal of Orthodontics and Dentofacial Orthopedics
COVID-19: What do we know?
- Research Article
85
- 10.2353/ajpath.2008.071060
- Jun 1, 2008
- The American Journal of Pathology
Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice
- Supplementary Content
248
- 10.1016/s2665-9913(20)30120-x
- May 20, 2020
- The Lancet Rheumatology
The immunology of COVID-19: is immune modulation an option for treatment?
- Research Article
23
- 10.1053/j.gastro.2021.09.009
- Sep 8, 2021
- Gastroenterology
Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
- Front Matter
25
- 10.1378/chest.126.3.670
- Sep 1, 2004
- Chest
Treatment of Severe Acute Respiratory Syndrome
- Discussion
21
- 10.1016/s0140-6736(21)02020-1
- Jan 1, 2021
- Lancet (London, England)
SARS-CoV-2's origin should be investigated worldwide for pandemic prevention
- Discussion
1
- 10.1053/j.jvca.2020.08.041
- Aug 26, 2020
- Journal of Cardiothoracic and Vascular Anesthesia
Testing the Asymptomatic Pre-Surgical Population for Severe Acute Respiratory Syndrome Coronavirus 2
- Discussion
6
- 10.1016/j.jinf.2022.06.021
- Jun 26, 2022
- The Journal of Infection
SNX27-mediated endocytic recycling of GLUT1 is suppressed by SARS-CoV-2 spike, possibly explaining neuromuscular disorders in patients with COVID-19
- Research Article
85
- 10.1111/j.1469-0691.2008.02016.x
- Jul 1, 2008
- Clinical Microbiology and Infection
Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences
- Research Article
188
- 10.1016/s2665-9913(20)30420-3
- Jan 7, 2021
- The Lancet. Rheumatology
COVID-19 vasculitis and novel vasculitis mimics.
- Research Article
49
- 10.1016/j.celrep.2022.111220
- Aug 1, 2022
- Cell reports
SummaryThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike N-terminal domain (NTD) remains poorly characterized despite enrichment of mutations in this region across variants of concern (VOCs). Here, we examine the contribution of the NTD to infection and cell-cell fusion by constructing chimeric spikes bearing B.1.617 lineage (Delta and Kappa variants) NTDs and generating spike pseudotyped lentivirus. We find that the Delta NTD on a Kappa or wild-type (WT) background increases S1/S2 cleavage efficiency and virus entry, specifically in lung cells and airway organoids, through use of TMPRSS2. Delta exhibits increased cell-cell fusogenicity that could be conferred to WT and Kappa spikes by Delta NTD transfer. However, chimeras of Omicron BA.1 and BA.2 spikes with a Delta NTD do not show more efficient TMPRSS2 use or fusogenicity. We conclude that the NTD allosterically modulates S1/S2 cleavage and spike-mediated functions in a spike context-dependent manner, and allosteric interactions may be lost when combining regions from more distantly related VOCs.
- Research Article
90
- 10.1016/j.xinn.2021.100080
- Jan 18, 2021
- The Innovation
Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir
- Front Matter
18
- 10.1053/j.jvca.2021.01.014
- Jan 15, 2021
- Journal of Cardiothoracic and Vascular Anesthesia
The Right Ventricle in COVID-19 Lung Injury: Proposed Mechanisms, Management, and Research Gaps